The Fibrotic Diseases Treatment Market Research underscores the role of clinical studies and innovations in shaping the therapeutic landscape. Research focuses on antifibrotic agents like nintedanib and pirfenidone, which have proven efficacy in slowing disease progression. Immunomodulators, corticosteroids, and enzyme replacement therapies complement treatment options, while oral dosage...